Business Manager Oncology - South Asia - Clinical Next Generation Sequencing at Thermo Fisher Scientific.
Did you know that the turnaround times (TATs) for oncology biomarker profiling can be as long as 25 days? This extended timeframe has a significant impact on patients' outcomes. To address this issue, we invite you to join our webinar on rapid molecular profiling, where we will discuss the importance of timely biomarker analysis and its role in optimizing patient outcomes. #thermofisheremp